GRIFOLS | GRF - Net Income


GRIFOLS reported EUR98.25M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alcon AG USD 217M 20M Dec/2025
Almirall EUR 19.58M 7M Dec/2025
Amadeus IT EUR 247.5M 113.3M Dec/2025
Amarin USD -1.22M 6.51M Dec/2025
argenx SE USD 532.95M 188.69M Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Cie Automotive EUR 149.91M 35.97M Dec/2025
Demant DKK 427M 690M Dec/2025
Ence Energia y Celulosa EUR -32.46M 17.36M Dec/2025
Essilor EUR 928M 459M Dec/2025
Ferrovial EUR 348M 192M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 327M 52.2M Dec/2025
Galapagos EUR 782.15M 984.26M Dec/2025
Genmab DKK 31M 370M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GRIFOLS EUR 98.25M 28.72M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Inditex EUR 1.6B 233M Dec/2025
Merck EUR 319M 583M Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Philips EUR 395M 211M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Smith & Nephew USD 293M 79M Dec/2025
UCB EUR 1.08B 608M Dec/2025
Viscofan EUR 51.29M 12.42M Dec/2025